Lukas Delasos

8PUBLICATIONS
79CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Biological physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.

Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti

|Apr 07, 2021
The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions.

Igor Odintsov, Allan J W Lui, Whitney J Sisso

|Nov 11, 2020
MET Exon 14-altered Lung Cancers and MET Inhibitor Resistance.

Robin Guo, Michael Offin, A Rose Brannon

|Jul 30, 2020
New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature.

Lukas Delasos, Christopher Bazewicz, Aleksandra Sliwinska

Pageof 2